BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 17355233)

  • 1. Olopatadine hydrochloride accelerates the recovery of skin barrier function in mice.
    Amano T; Takeda T; Yano H; Tamura T
    Br J Dermatol; 2007 May; 156(5):906-12. PubMed ID: 17355233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olopatadine ameliorates rat experimental cutaneous inflammation by improving skin barrier function.
    Tamura T; Matsubara M; Amano T; Chida M
    Pharmacology; 2008; 81(2):118-26. PubMed ID: 17962722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barium sulphate with a negative zeta potential accelerates skin permeability barrier recovery and prevents epidermal hyperplasia induced by barrier disruption.
    Fuziwara S; Ogawa K; Aso D; Yoshizawa D; Takata S; Denda M
    Br J Dermatol; 2004 Sep; 151(3):557-64. PubMed ID: 15377340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of indomethacin and dexamethasone on mechanical scratching-induced cutaneous barrier disruption in mice.
    Honma Y; Arai I; Sakurai T; Futaki N; Hashimoto Y; Sugimoto M; Nakanishi Y; Nakaike S
    Exp Dermatol; 2006 Jul; 15(7):501-8. PubMed ID: 16761958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of olopatadine hydrochloride, an antihistamine drug, on skin inflammation induced by repeated topical application of oxazolone in mice.
    Tamura T; Matsubara M; Takada C; Hasegawa K; Suzuki K; Ohmori K; Karasawa A
    Br J Dermatol; 2004 Dec; 151(6):1133-42. PubMed ID: 15606507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity.
    Tamura T; Matsubara M; Hasegawa K; Ohmori K; Karasawa A
    Clin Exp Allergy; 2005 Jan; 35(1):97-103. PubMed ID: 15649273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary glucosylceramide improves skin barrier function in hairless mice.
    Tsuji K; Mitsutake S; Ishikawa J; Takagi Y; Akiyama M; Shimizu H; Tomiyama T; Igarashi Y
    J Dermatol Sci; 2006 Nov; 44(2):101-7. PubMed ID: 17000082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a murine model to evaluate the effect of vernix caseosa on skin barrier recovery.
    Oudshoorn MH; Rissmann R; van der Coelen D; Hennink WE; Ponec M; Bouwstra JA
    Exp Dermatol; 2009 Feb; 18(2):178-84. PubMed ID: 18684123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin D2 and prostaglandin E2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice.
    Honma Y; Arai I; Hashimoto Y; Futaki N; Sugimoto M; Tanaka M; Nakaike S
    Eur J Pharmacol; 2005 Jul; 518(1):56-62. PubMed ID: 16000196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous effect of ursolic acid and oleanolic acid on epidermal permeability barrier function and epidermal keratinocyte differentiation via peroxisome proliferator-activated receptor-alpha.
    Lim SW; Hong SP; Jeong SW; Kim B; Bak H; Ryoo HC; Lee SH; Ahn SK
    J Dermatol; 2007 Sep; 34(9):625-34. PubMed ID: 17727365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olopatadine hydrochloride improves dermatitis score and inhibits scratch behavior in NC/Nga mice.
    Murota H; El-latif MA; Tamura T; Amano T; Katayama I
    Int Arch Allergy Immunol; 2010; 153(2):121-32. PubMed ID: 20407268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous barrier repair and pathophysiology following barrier disruption in IL-1 and TNF type I receptor deficient mice.
    Man MQ; Wood L; Elias PM; Feingold KR
    Exp Dermatol; 1999 Aug; 8(4):261-6. PubMed ID: 10439223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a mouse skin model of the lichenification in human chronic eczematous dermatitis.
    Matsunaga Y; Ogura Y; Ehama R; Amano S; Nishiyama T; Tagami H
    Br J Dermatol; 2007 May; 156(5):884-91. PubMed ID: 17326747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of olopatadine and other histamine H1 receptor antagonists on the skin inflammation induced by repeated topical application of oxazolone in mice.
    Tamura T; Masaki S; Ohmori K; Karasawa A
    Pharmacology; 2005 Dec; 75(1):45-52. PubMed ID: 15942272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of olopatadine hydrochloride on the number of scratching induced by repeated application of oxazolone in mice.
    Tamura T; Amano T; Ohmori K; Manabe H
    Eur J Pharmacol; 2005 Nov; 524(1-3):149-54. PubMed ID: 16259975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide analogue 14S24 selectively recovers perturbed human skin barrier.
    Vávrová K; Hrabálek A; Mac-Mary S; Humbert P; Muret P
    Br J Dermatol; 2007 Oct; 157(4):704-12. PubMed ID: 17711529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tape stripping and sodium dodecyl sulfate treatment increase the molecular weight cutoff of polyethylene glycol penetration across murine skin.
    Tsai JC; Shen LC; Sheu HM; Lu CC
    Arch Dermatol Res; 2003 Aug; 295(4):169-74. PubMed ID: 12910356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of repeated pretreatment with olopatadine hydrochloride on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
    Tamura T; Kimoto N
    Pharmacology; 2009; 84(5):288-93. PubMed ID: 19816088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of skin barrier function in allergic contact dermatitis and atopic dermatitis using method of the continuous TEWL measurement.
    Laudańska H; Reduta T; Szmitkowska D
    Rocz Akad Med Bialymst; 2003; 48():123-7. PubMed ID: 14737957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin type, but neither race nor gender, influence epidermal permeability barrier function.
    Reed JT; Ghadially R; Elias PM
    Arch Dermatol; 1995 Oct; 131(10):1134-8. PubMed ID: 7574829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.